Show simple item record

dc.contributor.authorCunningham, C
dc.contributor.authorCampion, S
dc.contributor.authorLunnon, K
dc.contributor.authorMurray, CL
dc.contributor.authorWoods, JFC
dc.contributor.authorDeacon, RMJ
dc.contributor.authorRawlins, JNP
dc.contributor.authorPerry, VH
dc.date.accessioned2018-10-04T11:46:17Z
dc.date.issued2008-09-18
dc.description.abstractBACKGROUND: Chronic neurodegeneration results in microglial activation, but the contribution of inflammation to the progress of neurodegeneration remains unclear. We have shown that microglia express low levels of proinflammatory cytokines during chronic neurodegeneration but are "primed" to produce a more proinflammatory profile after systemic challenge with bacterial endotoxin (lipopolysaccharide [LPS]). METHODS: Here, we investigated whether intraperitoneal (IP) challenge with LPS, to mimic systemic infection, in the early stages of prion disease can 1) produce exaggerated acute behavioral (n = 9) and central nervous system (CNS) inflammatory (n = 4) responses in diseased animals compared with control animals, and 2) whether a single LPS challenge can accelerate disease progression (n = 34-35). RESULTS: Injection of LPS (100 microg/kg), at 12 weeks postinoculation (PI), resulted in heightened CNS interleukin-1 beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), and interferon-beta (IFN-beta) transcription and microglial IL-1beta translation in prion-diseased animals relative to control animals. This inflammation caused exaggerated impairments in burrowing and locomotor activity, and induced hypothermia and cognitive changes in prion-diseased animals that were absent in LPS-treated control animals. At 15 weeks PI, LPS (500 microg/kg) acutely impaired motor coordination and muscle strength in prion-diseased but not in control animals. After recovery, these animals also showed earlier onset of disease-associated impairments on these parameters. CONCLUSIONS: These data demonstrate that transient systemic inflammation superimposed on neurodegenerative disease acutely exacerbates cognitive and motor symptoms of disease and accelerates disease progression. These deleterious effects of systemic inflammation have implications for the treatment of chronic neurodegeneration and associated delirium.en_GB
dc.description.sponsorshipWe gratefully acknowledge the financial support of the Wellcome Trust.en_GB
dc.identifier.citationVol. 65 (4), pp. 304 - 312en_GB
dc.identifier.doi10.1016/j.biopsych.2008.07.024
dc.identifier.urihttp://hdl.handle.net/10871/34192
dc.language.isoenen_GB
dc.publisherElsevier for Society of Biological Psychiatryen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/18801476en_GB
dc.rightsCopyright © 2009 Society of Biological Psychiatry. Published by Elsevier Inc. Open Access funded by Wellcome Trust. Under a Creative Commons license: https://creativecommons.org/licenses/by/4.0/en_GB
dc.subjectAnimalsen_GB
dc.subjectBehavior, Animalen_GB
dc.subjectBody Temperatureen_GB
dc.subjectCognitionen_GB
dc.subjectFemaleen_GB
dc.subjectImmunohistochemistryen_GB
dc.subjectInflammationen_GB
dc.subjectInfusions, Parenteralen_GB
dc.subjectLipopolysaccharidesen_GB
dc.subjectLongitudinal Studiesen_GB
dc.subjectMaze Learningen_GB
dc.subjectMiceen_GB
dc.subjectMice, Inbred C57BLen_GB
dc.subjectMotor Activityen_GB
dc.subjectNeurodegenerative Diseasesen_GB
dc.subjectPsychomotor Performanceen_GB
dc.subjectReverse Transcriptase Polymerase Chain Reactionen_GB
dc.titleSystemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease.en_GB
dc.typeArticleen_GB
dc.date.available2018-10-04T11:46:17Z
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the final version. Available from Elsevier via the DOI in this record.en_GB
dc.identifier.journalBiological Psychiatryen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record